Your browser doesn't support javascript.
loading
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
Chelliah, Vijayalakshmi; Lazarou, Georgia; Bhatnagar, Sumit; Gibbs, John P; Nijsen, Marjoleen; Ray, Avijit; Stoll, Brian; Thompson, R Adam; Gulati, Abhishek; Soukharev, Serguei; Yamada, Akihiro; Weddell, Jared; Sayama, Hiroyuki; Oishi, Masayo; Wittemer-Rump, Sabine; Patel, Chirag; Niederalt, Christoph; Burghaus, Rolf; Scheerans, Christian; Lippert, Jörg; Kabilan, Senthil; Kareva, Irina; Belousova, Natalya; Rolfe, Alex; Zutshi, Anup; Chenel, Marylore; Venezia, Filippo; Fouliard, Sylvain; Oberwittler, Heike; Scholer-Dahirel, Alix; Lelievre, Helene; Bottino, Dean; Collins, Sabrina C; Nguyen, Hoa Q; Wang, Haiqing; Yoneyama, Tomoki; Zhu, Andy Z X; van der Graaf, Piet H; Kierzek, Andrzej M.
Afiliação
  • Chelliah V; Certara UK Ltd., Sheffield, UK.
  • Lazarou G; Certara UK Ltd., Sheffield, UK.
  • Bhatnagar S; Abbvie Inc., North Chicago, Illinois, USA.
  • Gibbs JP; Abbvie Inc., North Chicago, Illinois, USA.
  • Nijsen M; Abbvie Inc., North Chicago, Illinois, USA.
  • Ray A; Abbvie Inc., North Chicago, Illinois, USA.
  • Stoll B; Abbvie Inc., North Chicago, Illinois, USA.
  • Thompson RA; Abbvie Inc., North Chicago, Illinois, USA.
  • Gulati A; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Soukharev S; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Yamada A; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Weddell J; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Sayama H; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Oishi M; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Wittemer-Rump S; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Patel C; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Niederalt C; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Burghaus R; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Scheerans C; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Northbrook, Illinois, USA.
  • Lippert J; Astellas Pharma Global Development Inc./Astellas Pharma Inc., Tokyo or Tsukuba-shi, Japan.
  • Kabilan S; Bayer AG, Leverkusen, Germany.
  • Kareva I; Bayer AG, Leverkusen, Germany.
  • Belousova N; Bayer AG, Leverkusen, Germany.
  • Rolfe A; Bayer AG, Leverkusen, Germany.
  • Zutshi A; Bayer AG, Leverkusen, Germany.
  • Chenel M; Bayer AG, Leverkusen, Germany.
  • Venezia F; EMD Serono, Merck KGaA, Billerica, Massachusetts, USA.
  • Fouliard S; EMD Serono, Merck KGaA, Billerica, Massachusetts, USA.
  • Oberwittler H; EMD Serono, Merck KGaA, Billerica, Massachusetts, USA.
  • Scholer-Dahirel A; EMD Serono, Merck KGaA, Billerica, Massachusetts, USA.
  • Lelievre H; EMD Serono, Merck KGaA, Billerica, Massachusetts, USA.
  • Bottino D; Servier, Suresnes, France.
  • Collins SC; Servier, Suresnes, France.
  • Nguyen HQ; Servier, Suresnes, France.
  • Wang H; Servier, Suresnes, France.
  • Yoneyama T; Servier, Suresnes, France.
  • Zhu AZX; Servier, Suresnes, France.
  • van der Graaf PH; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts, USA.
  • Kierzek AM; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts, USA.
Clin Pharmacol Ther ; 109(3): 605-618, 2021 03.
Article em En | MEDLINE | ID: mdl-32686076
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biologia de Sistemas / Alergia e Imunologia / Simulação de Dinâmica Molecular / Desenvolvimento de Medicamentos / Inibidores de Checkpoint Imunológico / Oncologia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biologia de Sistemas / Alergia e Imunologia / Simulação de Dinâmica Molecular / Desenvolvimento de Medicamentos / Inibidores de Checkpoint Imunológico / Oncologia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido